Literature DB >> 15707471

Factors influencing the switch in the use of antihypertensive medications.

C-C Chou1, M-S Lee, C-H Ke, M-H Chuang.   

Abstract

The present study was undertaken to explore factors associated with observance of prescribed antihypertensive medications. Secondary data analysis utilising ambulatory claims of the Taiwan National Health Insurance involved all initially treated hypertensive patients (n=565,048) from June 1, 1997 to June 30, 1998. The main outcome measure was the statistical analysis of factors prompting medication switch and dropout rates. The overall continuity rate was 51%. Specific continuity rates were 40% for calcium antagonists, 36% for angiotensin-converting enzyme inhibitors, 35% for beta-blockers and 29% for diuretics. Less than 30% of patients changed medications and more than 20% of patients changed clinics. The change increased the likelihood of switching medications sevenfold. Switch was minimal for calcium antagonists. Patients taking calcium antagonists were the least likely to switch medications and had the lowest dropout rate. Changing clinics was the most influential medication switch factor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15707471     DOI: 10.1111/j.1742-1241.2005.00436.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  4 in total

1.  Difference of antihypertensive prescribing between office- and hospital-based clinics in Taiwan.

Authors:  Wei-Liang Chen; Tung-Wei Kao; Chung-Ching Wang; Yaw-Wen Chang; Li-Wei Wu; Mark L Wahlqvist; Chih-Chieh Chou
Journal:  Int J Clin Pharm       Date:  2012-07-10

2.  Switching of antihypertensive drugs at Tertiary Care Government Hospital, Hyderabad, India: A cross-sectional retrospective investigation.

Authors:  Varsha Varakantham; Ashok Kumar Kurakula Sailoo; Venkaiah Kodali; Dinesh Kumar Bharatraj
Journal:  Indian J Pharmacol       Date:  2017 Nov-Dec       Impact factor: 1.200

3.  Initial antihypertensive prescription and switching: a 5 year cohort study from 250,851 patients.

Authors:  Martin C S Wong; Wilson W S Tam; Clement S K Cheung; Ellen L H Tong; Antonio C H Sek; George John; N T Cheung; Bryan P Y Yan; C M Yu; Stephen Leeder; Sian Griffiths
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

4.  Higher persistence with valsartan compared with enalapril in daily practice.

Authors:  Satu J Siiskonen; Nancy S Breekveldt-Postma; Gábor Vincze; Zeba M Khan; Joëlle A Erkens; Ron M C Herings
Journal:  Vasc Health Risk Manag       Date:  2007
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.